Suppr超能文献

与原发性胰腺神经内分泌肿瘤相比,同步性神经内分泌肝转移瘤的MRI及SSR-PET/CT表现

Synchronous neuroendocine liver metastases in comparison to primary pancreatic neuroendocrine tumors on MRI and SSR-PET/CT.

作者信息

Horng Annie, Ingenerf Maria, Berger Frank, Steffinger Denise, Rübenthaler Johannes, Zacherl Matthias, Wenter Vera, Ricke Jens, Schmid-Tannwald Christine

机构信息

Department of Radiology, University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, Munich, Germany.

Department of Nuclear Medicine, University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, Munich, Germany.

出版信息

Front Oncol. 2024 May 31;14:1352538. doi: 10.3389/fonc.2024.1352538. eCollection 2024.

Abstract

BACKGROUND

The study aimed to compare and correlate morphological and functional parameters in pancreatic neuroendocrine tumors (pNET) and their synchronous liver metastases (NELM), while also assessing prognostic imaging parameters.

METHODS

Patients with G1/G2 pNET and synchronous NELM underwent pretherapeutic abdominal MRI with DWI and 68Ga-DOTATATE/TOC PET/CT were included. ADC (mean, min), SNR_art and SNT_T2 (SNR on arterial phase and on T2) and SUV (max, mean) for three target NELM and pNET, as well as tumor-free liver and spleen (only in PET/CT) were measured. Morphological parameters including size, location, arterial enhancement, cystic components, T2-hyperintensity, ductal dilatation, pancreatic atrophy, and vessel involvement were noted. Response evaluation used progression-free survival (PFS) with responders (R;PFS>24 months) and non-responders (NR;PFS ≤ 24 months).

RESULTS

33 patients with 33 pNETs and 95 target NELM were included. There were no significant differences in ADC and SUV values between NELM and pNET. 70% of NELM were categorized as hyperenhancing lesions, whereas the pNETs exhibited significantly lower rate (51%) of hyperenhancement (p<0.01) and significant lower SNR_art. NELM were qualitatively and quantitatively (SNR_T2) significantly more hyperintense on T2 compared to pNET (p=0.01 and p<0.001). NELM of R displayed significantly lower ADCmean value in comparison to the ADC mean value of pNET (0.898 versus 1.037x10mm²/s,p=0.036). In NR, T2-hyperintensity was notably higher in NELM compared to pNET (p=0.017). The hepatic tumor burden was significantly lower in the R compared to the NR (10% versus 30%).

CONCLUSIONS

Arterial hyperenhancement and T2-hyperintensity differ between synchronous NELM and pNET. These findings emphasize the importance of a multifaceted approach to imaging and treatment planning in patients with these tumors as well as in predicting treatment responses.

摘要

背景

本研究旨在比较胰腺神经内分泌肿瘤(pNET)及其同步肝转移瘤(NELM)的形态学和功能参数,并进行相关性分析,同时评估预后影像学参数。

方法

纳入G1/G2期pNET及同步NELM患者,术前行腹部MRI检查,包括弥散加权成像(DWI),并进行68Ga-DOTATATE/TOC PET/CT检查。测量三个目标NELM和pNET的表观扩散系数(ADC,平均值、最小值)、动脉期信噪比(SNR_art)和T2加权像信噪比(SNT_T2)以及标准化摄取值(SUV,最大值、平均值),同时测量无肿瘤肝脏和脾脏(仅在PET/CT检查中)的上述参数。记录形态学参数,包括大小、位置、动脉期强化、囊性成分、T2高信号、导管扩张、胰腺萎缩和血管受累情况。采用无进展生存期(PFS)评估疗效,将患者分为反应者(R;PFS>24个月)和无反应者(NR;PFS≤24个月)。

结果

纳入33例患者,共33个pNET和95个目标NELM。NELM和pNET的ADC值和SUV值无显著差异。70%的NELM为动脉期强化病变,而pNET的动脉期强化率显著较低(51%)(p<0.01),且SNR_art显著较低。与pNET相比,NELM在T2加权像上的定性和定量(SNR_T2)高信号更为显著(p=0.01和p<0.001)。反应者组的NELM的ADC平均值显著低于pNET的ADC平均值(0.898对1.037x10mm²/s,p=0.036)。在无反应者组中,NELM的T2高信号显著高于pNET(p=0.017)。反应者组的肝脏肿瘤负荷显著低于无反应者组(10%对30%)。

结论

同步NELM和pNET在动脉期强化和T2高信号方面存在差异。这些发现强调了对这些肿瘤患者进行多方面成像和治疗计划以及预测治疗反应的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/393c/11179428/14087c6ecb2b/fonc-14-1352538-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验